Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • AbbVie inks $745M deal with Chinese biotech Haisco for two acute pain assets

AbbVie inks $745M deal with Chinese biotech Haisco for two acute pain assets

  • April 13, 2026

AbbVie has agreed to pay $30 million upfront to Chinese biotech Haisco Pharmaceutical Group for two non-opioid pain treatment candidates.

Leave A Comment

Fields (*) Mark are Required